Clinical Evaluation on the Longevity of Glass Ceramic Based Single Tooth Restorations
Launched by IVOCLAR VIVADENT AG · Mar 20, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how long certain types of dental restorations last. Specifically, it focuses on glass-ceramic single tooth restorations made from materials called IPS e.max CAD and IPS e.max Press, which have been in place for more than 15 years. The goal is to find out how well these restorations hold up over time and to evaluate their appearance, function, and health impact.
To participate in the study, you need to be at least 18 years old and have had an indirect single tooth restoration (like an inlay, onlay, veneer, or crown) done at a specific clinic between 2006 and 2010 using the mentioned materials. You must also be able to visit the clinic in Schaan, FL, and be in good enough health to take part. If you join the study, you’ll help researchers learn more about the longevity and quality of these dental restorations, which could benefit future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: \> 18 years
- • Informed consent signed and understood by the subject
- • Received indirect single tooth restoration (inlay, onlay, veneer or crown) within the internal clinic of Ivoclar Vivadent AG between 2006 and 2010
- • Single tooth restoration was done with IPS e.max CAD or IPS e.max Press
- • Able to visit the internal clinic of Ivoclar Vivadent AG in Schaan, FL.
- Exclusion Criteria:
- • Health status (physical and mental) does not allow participation
About Ivoclar Vivadent Ag
Ivoclar Vivadent AG is a leading global manufacturer of innovative dental materials and equipment, dedicated to enhancing oral health and aesthetics. With a strong emphasis on research and development, the company focuses on creating high-quality solutions that meet the evolving needs of dental professionals and their patients. Ivoclar Vivadent AG is committed to advancing dental science through rigorous clinical trials, ensuring the efficacy and safety of its products while fostering a culture of excellence and sustainability in oral healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schaan, , Liechtenstein
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported